The national and subnational burden of prostate cancer in Italy from 1990 to 2021: results from the Global Burden of Disease Study 2021 — Elisa Fabbro (2025) | RDL Network
The national and subnational burden of prostate cancer in Italy from 1990 to 2021: results from the Global Burden of Disease Study 2021
Article 2025 en
Authors
EF
Elisa Fabbro
GZ
Giulia Zamagni
GC
Giulia Carreras
Abstract
1 min read
PCa remains a critical health issue in Italy. The reduction in ASMR and ASDR indicates progress in early diagnosis and treatment. However, subnational disparities in incidence and mortality highlight the need for targeted healthcare interventions.
Cristina Bosetti, Eugenio Traini, Shazia Alam, Christine A. Allen, Giulia Carreras, Kelly Compton, Christina Fitzmaurice, Lisa M Force, Silvano Gallus, Giuseppe Gorini, James Harvey, Jonathan Kocarnik, Carlo La Vecchia, Alessandra Lugo, Mohsen Naghavi, Alyssa Pennini, Cristiano Piccinelli, Luca Ronfani, Rixing Xu, Lorenzo Monasta
Giulia Zamagni, Benedetta Armocida, Giulio Castelpietra, Sara Conti, Paolo Angelo Cortesi, Pietro Ferrara, C Fornari, Silvano Gallus, Matilde Leonardi, Roberto Passera, Norberto Perico, Alberto Raggi, Giuseppe Remuzzi, Luca Ronfani, Lorenzo Monasta
Yun Seo Kim, Min Seo Kim, Seoyeon Park, Lee Smith, Joaquim Raduà, Sarah Soyeon Oh, Stefania Papatheodorou, Hoon‐Chul Kang, Ara Ko, Dong Keon Yon, Jae Il Shin
Discussion(0)
No comments yet. Be the first to comment.